SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001145443-21-000105
Filing Date
2021-02-04
Accepted
2021-02-03 20:55:39
Documents
1
Group Members
MIMLMIMUS

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP tt3865661-sc13ga.htm SC 13G/A 106424
  Complete submission text file 0001145443-21-000105.txt   108176
Mailing Address 200 BLOOR ST EAST, NT-10 TORONTO A6 M4W1E5
Business Address 200 BLOOR ST EAST, NT-10 TORONTO A6 M4W1E5 416-926-3000
MANULIFE FINANCIAL CORP (Filed by) CIK: 0001086888 (see all company filings)

IRS No.: 889897526 | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6311 Life Insurance

Mailing Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 888-969-7879
Travere Therapeutics, Inc. (Subject) CIK: 0001438533 (see all company filings)

IRS No.: 262383102 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87088 | Film No.: 21588416
SIC: 2834 Pharmaceutical Preparations